MEDICINOVA, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
MEDICINOVA, INC. (MNOV) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of -0.20% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-03-10
- MEDICINOVA, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2025 was -0.20%.
- MEDICINOVA, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2024 was -0.70%.
- MEDICINOVA, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2023 was -1.90%.
- MEDICINOVA, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2022 was -1.90%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -0.20% 10-K · filed 2026-03-10 | |
| 2024-12-31 | -0.70% 10-K · filed 2026-03-10 | -4.00% 10-K · filed 2025-02-19 |
| 2023-12-31 | -1.90% 10-K · filed 2025-02-19 | |
| 2022-12-31 | -1.90% 10-K · filed 2024-02-15 | |
| 2021-12-31 | -12.40% 10-K/A · filed 2023-03-28 | |
| 2020-12-31 | -5.20% 10-K · filed 2022-02-16 | |
| 2019-12-31 | -11.10% 10-K · filed 2021-02-19 | |
| 2018-12-31 | -1.70% 10-K · filed 2020-02-13 | |
| 2017-12-31 | -2.90% 10-K · filed 2019-02-13 | |
| 2016-12-31 | -13.60% 10-K · filed 2019-02-13 | 13.60% 10-K · filed 2017-02-14 |
| 2015-12-31 | -3.40% 10-K · filed 2018-02-13 | 3.40% 10-K · filed 2016-02-25 |
| 2014-12-31 | 2.60% 10-K · filed 2017-02-14 | -2.60% 10-K · filed 2015-03-12 |
| 2013-12-31 | 20.00% 10-K · filed 2015-03-12 | |
| 2012-12-31 | -12.60% 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |